Jennifer Wenzel on the Importance of Including Minority Patients in Clinical Trials

JENNIFER WENZEL, PHD, RN, CCN, FAAN
Friday, April 21, 2017
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Jennifer Wenzel, PhD, RN, CCN, FAAN, of Johns Hopkins University School of Nursing, discusses the importance of including minority patients in clinical trials.

Minority patients in particular may feel an extra burden to benefit the community at large. Most minority patients understand that their population has been left behind in medical research. Because of that, they want their experience to be able to benefit their community at large. Nurses have an important role in extending the opportunity for clinical trial participation to underrepresented groups and to help them succeed.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.